Clinical Trials Directory

Trials / Completed

CompletedNCT02141165

Home Nasal Pressure for Sleep Apnea Management in Primary Case

Efficacy and Cost-Effectiveness of a Super Simplified System for the Management of Patients With Sleep Apneas in Primary Healthcare.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
280 (actual)
Sponsor
Sociedad Española de Neumología y Cirugía Torácica · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Primary objectives: To determine the efficacy and cost-effectiveness of a management program for patients with obstructive sleep apnea syndrome (OSAS) carried out in primary or specialist healthcare. In the primary arm, the diagnosis and therapeutic decision will be made by means of a domiciliary nasal pressure (DNP) channel and oximetry while the specialist healthcare arm will use polysomnography (PSG) in a hospital. Patients with an intermediate-high suspicion of OSAS will be included, taking as primary variables the Epworth scale, for efficacy, and the Epworth scale and EuroQol 5D, for cost-effectiveness. Secondary objectives: efficacy of the two SAHS management programs according to the following secondary variables: a) quality-of-life tests: FOSQ questionnaire, SF36 and analogical wellbeing scale, b) adherence to and compliance with the treatment.

Detailed description

Design: prospective, randomized, controlled, open, parallel, non-inferiority. A total of 280 patients will be randomized for management on the basis of DNP (primary) or PSG (specialist), thereby giving rise to 4 groups: two treated and two not treated with CPAP. The former will undergo a home auto-titration. The follow-up will last 6 months and include 4 evaluations.

Conditions

Interventions

TypeNameDescription
DEVICEDiagnosis, autoCPAP, follow up.comparison between the efficacy of two protocol

Timeline

Start date
2014-03-01
Primary completion
2016-04-01
Completion
2017-03-01
First posted
2014-05-19
Last updated
2017-03-15

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT02141165. Inclusion in this directory is not an endorsement.